Incyte Reports 2015 Second-Quarter Financial Results and Updates Shareholders on Key Clinical Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. SPCX
3. MU
4. ACN
5. IBM
6. SPY
7. TSLA
8. DPZ
9. NVDA
10. PRIM

Go back to Incyte Reports 2015 Second-Quarter Financial Results and Updates Shareholders on Key Clinical Programs

Incyte (INCY) Tops Q2 EPS by 6c; Raises Jakafi Sales Guidance

August 4, 2015 7:16 AM EDT

Incyte (NASDAQ: INCY) reported Q2 EPS of ($0.05), $0.06 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $162.98 million versus the consensus estimate of $153.27 million.

For the quarter ended June 30, 2015, net product revenues of Jakafi were $142 million as compared to $84 million for... More